Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- Kitabis Pak (tobramycin)
- oxaprozin
Interactions between your drugs
tobramycin oxaprozin
Applies to: Kitabis Pak (tobramycin), oxaprozin
Tobramycin can sometimes cause kidney damage, and using it with oxaprozin may increase that risk, particularly if the latter is used chronically for prolonged periods. Talk to your doctor if you have any questions or concerns. Your doctor may already be aware of the risks, but has determined that this is the best course of treatment for you and has taken appropriate precautions and is monitoring you closely for any potential complications. Signs and symptoms of kidney damage may include nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Let your doctor know if you experience some or all of these problems during treatment. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
oxaprozin food
Applies to: oxaprozin
Ask your doctor before using oxaprozin together with ethanol (alcohol). Do not drink alcohol while taking oxaprozin. Alcohol can increase your risk of stomach bleeding caused by oxaprozin. Call your doctor at once if you have symptoms of bleeding in your stomach or intestines. This includes black, bloody, or tarry stools, or coughing up blood or vomit that looks like coffee grounds. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Zithromax
Zithromax (azithromycin) treats infections caused by bacteria, such as respiratory infections, skin ...
Creon
Creon (pancrelipase) contains digestive enzymes and is used to improve food digestion in people who ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Azithromycin Dose Pack
Azithromycin Dose Pack is used for babesiosis, bacterial endocarditis prevention, bacterial ...
Zenpep
Zenpep (pancrealipase) is used to replace pancreatic enzymes when the body does not have enough of ...
Trikafta
Trikafta is used to treat adults and children aged 2 years and older with cystic fibrosis (CF) with ...
Pulmozyme
Pulmozyme is used to improve lung function in people with cystic fibrosis. Learn about side ...
Pancreaze
Pancreaze (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Pancreaze ...
Alyftrek
Alyftrek is used to treat cystic fibrosis (CF) in people aged 6 years and older with at least one ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.